This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignees: Koninklijke Philips Corporation N.v., Bracco Suisse Sa. Active years: 2021-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2021-2022
Title: The Innovations of Jean-Marc Paul Robert Hyvelin
Introduction
Jean-Marc Paul Robert Hyvelin is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of therapeutic ultrasound, particularly in the treatment of vascular conditions. With a total of two patents to his name, Hyvelin's work focuses on enhancing the efficacy of ultrasound therapies.
Latest Patents
Hyvelin's latest patents include "Interleaved beam pattern for sonothrombolysis and other vascular acoustic resonator mediated therapies." This patent describes a therapeutic ultrasound system that transmits a staggered or interleaved pattern of therapy beams. The technique minimizes the destruction of microbubbles due to adjacent beams and ensures uniform sonication of the targeted region. It also provides a means for bubble replenishment to maximize clot lysis from ultrasound. The second patent, "Devices and methods for the ultrasound treatment of ischemic stroke," outlines ultrasonic sonothrombolysis systems that produce two acoustic pressure levels during stroke therapy. This system aims to induce microbubble-mediated blood clot lysis while simultaneously stimulating reperfusion of the affected tissue.
Career Highlights
Throughout his career, Hyvelin has worked with prominent companies such as Koninklijke Philips Corporation N.V. and Bracco Suisse SA. His experience in these organizations has allowed him to develop innovative solutions in the field of medical technology.
Collaborations
Hyvelin has collaborated with notable professionals in his field, including Jeffry E Powers and Ralf Seip. These collaborations have contributed to the advancement of his research and the development of his patents.
Conclusion
Jean-Marc Paul Robert Hyvelin's contributions to therapeutic ultrasound demonstrate his commitment to improving medical treatments. His innovative patents reflect a deep understanding of the complexities involved in vascular therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile